Caricamento quotazioni...
Previsioni
Non sono disponibili dati degli analisti per questa azienda.
Notizie Vai al feed delle notizie
Else Nutrition raises gross margin to 34% and cuts expenses significantly
Else Nutrition reported Q3 2025 revenue of $1.66m (prior year $1.79m), an improved gross margin of 34% versus -9% a year earlier, and a 68% reduction in operating expenses to $1.15m. Monthly cash burn was reduced to below $200,000; the company is targeting cash-flow breakeven by late 2026 to early 2027. Else continues to focus on product innovation in plant‑based infant nutrition, expanding its U.S. presence, ongoing clinical studies, and has completed a 10:1 share consolidation. » Altro su de.investing.com
Else Nutrition reports quarterly figures: EPS improved, revenue slightly down
Else Nutrition released numbers for the quarter ended 30.09.2025 with earnings per share (EPS) of -0.02 CAD compared with -0.700 CAD a year earlier. Revenue fell 7.26 percent to 1.7 million CAD (prior year: 1.8 million CAD). » Altro su finanzen.net
Else Nutrition reports revenue decline, aims for positive cash flow by 2027
Else Nutrition reported a revenue decline in Q2 2025 to $1.5 million from $2.6 million a year earlier, improved its net loss to $1.4 million (−43%), and cut operating expenses by almost 60%. The company is pursuing operational restructuring, expanding its online business, pushing international expansion and evaluating new product categories and partnerships. Ready-to-drink children’s shakes are now available in Walmart stores, but the launch of an adult product line was delayed due to cash-flow constraints. Else Nutrition aims to reach cash-flow break-even in late 2026 to early 2027. » Altro su de.investing.com
Dati finanziari dell'azienda
| (EUR) | mar 2026 | |
|---|---|---|
| Ricavi | 917,04K | 31,52% |
| Utile lordo | -12,46K | 103,81% |
| Utile netto | -347,63K | 84,24% |
| EBITDA | -372,55K | 81,99% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 256,62K € |
Numero di azioni | 1,66 Mln |
Massimo/minimo a 52 settimane | 0,32 € - 0,00863 € |
| Dividendi | No |
Beta | 0,97 |
Rapporto P/E | -0,01 |
Rapporto PEG | 0,00 |
Rapporto P/B | -0,02 |
Rapporto P/S | 0,01 |
Profilo aziendale
Else Nutrition Holdings Inc. beschäftigt sich mit der Entwicklung, der Produktion und dem Verkauf von Nahrungsmitteln und Ernährungsprodukten für Säuglinge, Kleinkinder, Kinder und Erwachsene in Nordamerika und Israel. Das Unternehmen bietet Baby-Snacks, Baby-Fütterungszubehör wie Flaschen und Sauger, pflanzliche Säuglingsnahrung, Nahrungsmittel für Kleinkinder, Kinder und Erwachsene sowie Ergänzungsnahrung an. Das Unternehmen bietet seine Produkte auch über das Internet an. Der Hauptsitz von Else Nutrition Holdings Inc. befindet sich in Tel Aviv-Yafo, Israel.
| Nome | Else Nutrition Holdings |
| CEO | Hamutal Yitzhak |
| Sede centrale | Tel Aviv,
Israele |
| Sito web | |
| Quotazione in borsa | 01/05/2012 |
| Dipendenti | 12 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
Toronto Stock Exchange | BABY.TO |
Pnk | BABYF |
Frankfurt | 0YL.F |
München | 0YL.MU |
Scopri gli asset
Gli azionisti di Else Nutrition Holdings investono anche nei seguenti asset

